1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Massachusetts >
  6. Sun Pharma Acquires DUSA Pharmaceuticals

M&A Deal Summary

Sun Pharma Acquires DUSA Pharmaceuticals

On December 20, 2012, Sun Pharma acquired medical products company DUSA Pharmaceuticals for 230M USD

Acquisition Highlights
  • This is Sun Pharma’s 4th transaction in the Medical Products sector.
  • This is Sun Pharma’s 5th largest (disclosed) transaction.
  • This is Sun Pharma’s 3rd transaction in the United States.
  • This is Sun Pharma’s 1st transaction in Massachusetts.

M&A Deal Summary
Date 2012-12-20
Target DUSA Pharmaceuticals
Sector Medical Products
Buyer(s) Sun Pharma
Deal Type Add-on Acquisition
Deal Value 230M USD
Advisor(s) Leerink Partners (Financial)
Reed Smith (Legal)

Target

DUSA Pharmaceuticals

Wilmington, Massachusetts, United States
DUSA Pharmaceuticals, Inc.® is a fully integrated specialty pharmaceutical company focused primarily on the development and marketing of its Levulan® photodynamic therapy (PDT) technology platform used in conjunction with it’s proprietary light source, the BLU-U® Blue Light Photodynamic Therapy Illuminator.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Sun Pharma

Mumbai, India
Category Company
Founded 1983
Sector Life Science
Employees43,000
Revenue 520.4B INR (2025)
DESCRIPTION

Sun Pharma is a specialty generic pharmaceutical company. Products are sold through drug stores, mass merchants, grocery stores, and gift/specialty stores. Sun Pharma was founded in 1983 and is based in Mumbai, Maharashtra.

DEAL STATS #
Overall 7 of 15
Sector: Medical Products M&A 4 of 5
Type: Add-on Acquisition M&A Deals 2 of 8
State: Massachusetts M&A 1 of 4
Country: United States M&A 3 of 7
Year: 2012 M&A 1 of 1
Size (of disclosed) 5 of 7
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-02-23 Caraco Pharmaceutical Laboratories

Detroit, Michigan, United States

Caraco Pharmaceutical Laboratories Ltd. is a developer, manufacturer and marketer of generic drugs for the prescription and over-the-counter markets.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-04-04 Ranbaxy Laboratories

New Delhi, India

Ranbaxy Limited is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranbaxy’s continued focus on R&D has resulted in several approvals in developed and emerging 4 markets, many of which incorporate proprietary Novel Drug Delivery Systems and technologies developed at its own labs.

Buy $4.0B
Mergr

Solution for

Product

Company

Legal